BACKGROUND: The incidences of non-Hodgkin's lymphoma and multiple myeloma are increasing steadily. It has been hypothesized that this may be due, in part, to the parallel rising prevalence of obesity. It is biologically plausible that anthropometric characteristics can infuence the risk of non-Hodgkin's lymphoma and multiple myeloma. DESIGN AND METHODS: In the context of the European Prospective Investigation into Cancer and Nutrition (EPIC), anthropometric characteristics were assessed in 371,983 cancer-free individuals at baseline. During the 8.5 years of follow-up, 1,219 histologically confirmed incident cases of non-Hodgkin's lymphoma and multiple myeloma occurred in 609 men and 610 women. Gender-specific proportional hazards models were used to estimate relative risks and 95% confidence intervals (95% CI) of development of non-Hodgkin's lymphoma and multiple myeloma in relation to the anthropometric characteristics. RESULTS: Height was associated with overall non-Hodgkin's lymphoma and multiple myeloma in women (RR 1.50, 95% CI 1.14-1.98) for highest versus lowest quartile; p-trend < 0.01) but not in men. Neither obesity (weight and body mass index) nor abdominal fat (waist-to-hip ratio, waist or hip circumference) measures were positively associated with overall non-Hodgkin's lymphoma and multiple myeloma. Relative risks for highest versus lowest body mass index quartile were 1.09 (95% CI 0.85-1.38) and 0.92 (95% CI 0.71-1.19) for men and women, respectively. Women in the upper body mass index quartile were at greater risk of diffuse large B-cell lymphoma (RR 2.18, 95% CI 1.05-4.53) and taller women had an elevated risk of follicular lymphoma (RR 1.25, 95% CI 0.59-2.62). Among men, height and body mass index were non-significantly, positively related to follicular lymphoma. Multiple myeloma risk alone was elevated for taller women (RR 2.34, 95% CI 1.29-4.21) and heavier men (RR 1.77, 95% CI 1.02-3.05). CONCLUSIONS: The EPIC analyses support an association between height and overall non-Hodgkin's lymphoma and multiple myeloma among women and suggest heterogeneous subtype associations. This is one of the first prospective studies focusing on central adiposity and non-Hodgkin's lymphoma subtypes.
BACKGROUND: The incidences of non-Hodgkin's lymphoma and multiple myeloma are increasing steadily. It has been hypothesized that this may be due, in part, to the parallel rising prevalence of obesity. It is biologically plausible that anthropometric characteristics can infuence the risk of non-Hodgkin's lymphoma and multiple myeloma. DESIGN AND METHODS: In the context of the European Prospective Investigation into Cancer and Nutrition (EPIC), anthropometric characteristics were assessed in 371,983 cancer-free individuals at baseline. During the 8.5 years of follow-up, 1,219 histologically confirmed incident cases of non-Hodgkin's lymphoma and multiple myeloma occurred in 609 men and 610 women. Gender-specific proportional hazards models were used to estimate relative risks and 95% confidence intervals (95% CI) of development of non-Hodgkin's lymphoma and multiple myeloma in relation to the anthropometric characteristics. RESULTS: Height was associated with overall non-Hodgkin's lymphoma and multiple myeloma in women (RR 1.50, 95% CI 1.14-1.98) for highest versus lowest quartile; p-trend < 0.01) but not in men. Neither obesity (weight and body mass index) nor abdominal fat (waist-to-hip ratio, waist or hip circumference) measures were positively associated with overall non-Hodgkin's lymphoma and multiple myeloma. Relative risks for highest versus lowest body mass index quartile were 1.09 (95% CI 0.85-1.38) and 0.92 (95% CI 0.71-1.19) for men and women, respectively. Women in the upper body mass index quartile were at greater risk of diffuse large B-cell lymphoma (RR 2.18, 95% CI 1.05-4.53) and taller women had an elevated risk of follicular lymphoma (RR 1.25, 95% CI 0.59-2.62). Among men, height and body mass index were non-significantly, positively related to follicular lymphoma. Multiple myeloma risk alone was elevated for taller women (RR 2.34, 95% CI 1.29-4.21) and heavier men (RR 1.77, 95% CI 1.02-3.05). CONCLUSIONS: The EPIC analyses support an association between height and overall non-Hodgkin's lymphoma and multiple myeloma among women and suggest heterogeneous subtype associations. This is one of the first prospective studies focusing on central adiposity and non-Hodgkin's lymphoma subtypes.
Authors: Ola Landgren; S Vincent Rajkumar; Ruth M Pfeiffer; Robert A Kyle; Jerry A Katzmann; Angela Dispenzieri; Qiuyin Cai; Lynn R Goldin; Neil E Caporaso; Joseph F Fraumeni; William J Blot; Lisa B Signorello Journal: Blood Date: 2010-04-26 Impact factor: 22.113
Authors: Christina A Clarke; Sally L Glaser; Scarlett L Gomez; Sophia S Wang; Theresa H Keegan; Juan Yang; Ellen T Chang Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-04-14 Impact factor: 4.254
Authors: Geoffrey C Kabat; Mimi Y Kim; Jennifer W Bea; Kerstin L Edlefsen; Lucile L Adams-Campbell; Anneclaire J De Roos; Thomas E Rohan Journal: Cancer Epidemiol Date: 2011-08-04 Impact factor: 2.984
Authors: Yani Lu; Jennifer Prescott; Jane Sullivan-Halley; Katherine D Henderson; Huiyan Ma; Ellen T Chang; Christina A Clarke; Pamela L Horn-Ross; Giske Ursin; Leslie Bernstein Journal: Am J Epidemiol Date: 2009-10-12 Impact factor: 4.897
Authors: O Landgren; B I Graubard; J A Katzmann; R A Kyle; I Ahmadizadeh; R Clark; S K Kumar; A Dispenzieri; A J Greenberg; T M Therneau; L J Melton; N Caporaso; N Korde; M Roschewski; R Costello; G M McQuillan; S V Rajkumar Journal: Leukemia Date: 2014-01-20 Impact factor: 11.528
Authors: Lauren R Teras; Cari M Kitahara; Brenda M Birmann; Patricia A Hartge; Sophia S Wang; Kim Robien; Alpa V Patel; Hans-Olov Adami; Elisabete Weiderpass; Graham G Giles; Pramil N Singh; Michael Alavanja; Laura E Beane Freeman; Leslie Bernstein; Julie E Buring; Graham A Colditz; Gary E Fraser; Susan M Gapstur; J Michael Gaziano; Edward Giovannucci; Jonathan N Hofmann; Martha S Linet; Gila Neta; Yikyung Park; Ulrike Peters; Philip S Rosenberg; Catherine Schairer; Howard D Sesso; Meir J Stampfer; Kala Visvanathan; Emily White; Alicja Wolk; Anne Zeleniuch-Jacquotte; Amy Berrington de González; Mark P Purdue Journal: Br J Haematol Date: 2014-05-23 Impact factor: 6.998
Authors: Jonathan N Hofmann; Steven C Moore; Unhee Lim; Yikyung Park; Dalsu Baris; Albert R Hollenbeck; Charles E Matthews; Todd M Gibson; Patricia Hartge; Mark P Purdue Journal: Am J Epidemiol Date: 2013-03-29 Impact factor: 4.897
Authors: Eleanor Kane; Christine F Skibola; Paige M Bracci; James R Cerhan; Laura Costas; Karin Ekström Smedby; Elizabeth A Holly; Marc Maynadié; Anne J Novak; Tracy J Lightfoot; Stephen M Ansell; Alex G Smith; Mark Liebow; Mads Melbye; Lindsay Morton; Silvia de Sanjosé; Susan L Slager; Sophia S Wang; Yawei Zhang; Tongzhang Zheng; Eve Roman Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-05-11 Impact factor: 4.254
Authors: Brenda M Birmann; Gabriella Andreotti; Anneclaire J De Roos; Nicola J Camp; Brian C H Chiu; John J Spinelli; Nikolaus Becker; Véronique Benhaim-Luzon; Parveen Bhatti; Paolo Boffetta; Paul Brennan; Elizabeth E Brown; Pierluigi Cocco; Laura Costas; Wendy Cozen; Silvia de Sanjosé; Lenka Foretová; Graham G Giles; Marc Maynadié; Kirsten Moysich; Alexandra Nieters; Anthony Staines; Guido Tricot; Dennis Weisenburger; Yawei Zhang; Dalsu Baris; Mark P Purdue Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-02-21 Impact factor: 4.254
Authors: Martha S Linet; Claire M Vajdic; Lindsay M Morton; Anneclaire J de Roos; Christine F Skibola; Paolo Boffetta; James R Cerhan; Christopher R Flowers; Silvia de Sanjosé; Alain Monnereau; Pierluigi Cocco; Jennifer L Kelly; Alexandra G Smith; Dennis D Weisenburger; Christina A Clarke; Aaron Blair; Leslie Bernstein; Tongzhang Zheng; Lucia Miligi; Jacqueline Clavel; Yolanda Benavente; Brian C H Chiu Journal: J Natl Cancer Inst Monogr Date: 2014-08